Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion.

Twyman RE.

Neurochem Res. 2017 Jul;42(7):2099-2115. doi: 10.1007/s11064-017-2300-2. Epub 2017 Jun 7. Review.

PMID:
28589521
2.

New avenues for anti-epileptic drug discovery and development.

Löscher W, Klitgaard H, Twyman RE, Schmidt D.

Nat Rev Drug Discov. 2013 Oct;12(10):757-76. doi: 10.1038/nrd4126. Epub 2013 Sep 20. Review.

PMID:
24052047
3.

Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.

Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE; EPMN-106/INT-28 Investigators.

Acta Neurol Scand. 2005 Oct;112(4):214-22.

PMID:
16146489
5.

Pharmacokinetic interactions of topiramate.

Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S.

Clin Pharmacokinet. 2004;43(12):763-80. Review.

PMID:
15355124
6.

Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans.

Bamber BA, Twyman RE, Jorgensen EM.

Br J Pharmacol. 2003 Mar;138(5):883-93.

7.

Antibodies to glutamate receptors: a role in excitatory dysregulation of the central nervous system?

Twyman RE, Rogers SW, Gahring LC, Carlson NG, Donevan SD.

Adv Neurol. 1999;79:535-41. Review. No abstract available.

PMID:
10514841
8.

The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor.

Bamber BA, Beg AA, Twyman RE, Jorgensen EM.

J Neurosci. 1999 Jul 1;19(13):5348-59.

9.
10.

The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.

Donevan SD, Beg A, Gunther JM, Twyman RE.

J Pharmacol Exp Ther. 1998 May;285(2):539-45.

PMID:
9580595
11.

Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform.

Lavoie AM, Tingey JJ, Harrison NL, Pritchett DB, Twyman RE.

Biophys J. 1997 Nov;73(5):2518-26.

12.
13.

Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration.

Gahring LC, Rogers SW, Twyman RE.

Neurology. 1997 Feb;48(2):494-500.

PMID:
9040745
14.

The role of autoimmunity to glutamate receptors in neurological disease.

Rogers SW, Twyman RE, Gahring LC.

Mol Med Today. 1996 Feb;2(2):76-81. Review.

PMID:
8796860
15.

Single cell reverse transcription-polymerase chain reaction (RT-PCR) and the GABA-A receptor.

Sudweeks SN, Twyman RE.

Neurochem Int. 1996 Feb;28(2):137-9. No abstract available.

PMID:
8719700
16.

Direct evidence for diazepam modulation of GABAA receptor microscopic affinity.

Lavoie AM, Twyman RE.

Neuropharmacology. 1996;35(9-10):1383-92.

PMID:
9014155
17.

Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.

Twyman RE, Gahring LC, Spiess J, Rogers SW.

Neuron. 1995 Apr;14(4):755-62.

18.
20.
21.
22.
23.
25.

Kinetic properties and regulation of GABAA receptor channels.

MacDonald RL, Twyman RE.

Ion Channels. 1992;3:315-43. Review.

PMID:
1384760
26.

Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylation.

Macdonald RL, Twyman RE, Ryan-Jastrow T, Angelotti TP.

Epilepsy Res Suppl. 1992;9:265-77. Review.

PMID:
1337441
29.

Cyclic AMP-dependent protein kinase decreases GABAA receptor current in mouse spinal neurons.

Porter NM, Twyman RE, Uhler MD, Macdonald RL.

Neuron. 1990 Dec;5(6):789-96.

30.
31.
32.
33.
34.

Pentobarbital and picrotoxin have reciprocal actions on single GABAA receptor channels.

Twyman RE, Rogers CJ, Macdonald RL.

Neurosci Lett. 1989 Jan 2;96(1):89-95.

35.

The role of anticoagulation in cavernous sinus thrombosis.

Levine SR, Twyman RE, Gilman S.

Neurology. 1988 Apr;38(4):517-22. Review.

PMID:
3281056
36.

Pentobarbital regulation of the kinetic properties of GABA receptor chloride channels.

Macdonald RL, Twyman RE, Rogers CJ, Weddle MG.

Adv Biochem Psychopharmacol. 1988;45:61-71. No abstract available.

PMID:
2459926
37.

Echocardiographic classification of complete atrioventricular canal defects.

Johnson GL, Twyman RE, Todd EP, Cottrill CM, Noonan JA.

Am Heart J. 1981 May;101(5):612-8.

PMID:
7223600

Supplemental Content

Loading ...
Support Center